Data shows SARS-CoV-2 human challenge studies safe in healthy young adults February 2, 2022 Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human…
Pakistanis can’t meet life-goals due to ‘Confidence Gap’ January 13, 2022 Standard Chartered latest survey into affluent (comprising emerging affluent, affluent and high net worth) consumers in 12 markets across Asia, Africa, the Middle East…
Spiritus Mundi intends IPO on London Stock Exchange November 4, 2021 LONDON, UK: Special purpose acquisition vehicle, Spiritus Mundi, intends to launch an initial public offering (IPO) on the Main Market of the London Stock…
Kingmaker Footwear resumes production at Vietnam factory October 12, 2021 HONG KONG: Kingmaker Footwear Holdings Limited has resumed production at the group’s factory in Binh Duong Province, Vietnam. Kingmaker Footwear had earlier notified temporary production halt…
LNG demand set for growth as global economies recover February 27, 2021 LONDON: Global liquefied natural gas (LNG) trade increased to 360 million tonnes in 2020, according to Shell’s latest annual LNG Outlook published today, despite…
Property and casualty insurers report 27.5% drop in net income during first nine months of 2020 February 8, 2021 JERSEY CITY: The private U.S. property and casualty (P&C) insurance industry’s net income after taxes dropped 27.5 percent to $35.1 billion in the first…
U.S. FDA approves Gilead’s antiviral Veklury (remdesivir) for treatment of COVID-19 October 22, 2020 FOSTER CITY: Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the antiviral drug Veklury (remdesivir) for the…
AstraZeneca’s COVID-19 long-acting antibody combination advances into Phase III clinical trials October 12, 2020 LONDON: AstraZeneca’s long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in more than 6,000 participants at sites in and…
Oncimmune announces UK Government funding for tool for use in COVID-19 October 6, 2020 LONDON: Oncimmune Holdings announced the award of funding from the ‘UK Research and Innovation (UKRI) Ideas to Address COVID-19’ programme, to support a joint…
Synairgen and Clinigen sign agreement for treatment of hospitalised patients with COVID-19 September 29, 2020 SOUTHAMPTON: Synairgen plc and Clinigen Group have signed an agreement to launch a Managed Access Program for Synairgen’s inhaled formulation of interferon beta (IFN-beta),…